Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

Clinical trial NCT00214955 · COMPLETED

Trial details

NCT number: NCT00214955
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Neuropathic Pain

Start date: 2005-09-01
Primary completion: 2006-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.